オルニチンアミノトランスフェラゼは,臓がんにおけるポリアミン合成をサポートする
Min-Sik Lee1,2,3, Courtney Dennis4, Insia Naqvi1,3
1Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA.
Nature
|March 29, 2023
まとめ
臓がん細胞は正常な組織とは異なり グルタミンからオルニチンを合成します この発見は,毒性が低下した臓管腺癌の新たな治療標的となる可能性がある.
科学分野:
- 腫瘍学
- 癌 代謝
- 生物化学
背景:
- 管腺がん (PDA) は予後が悪い致命的な癌です.
- 腫瘍の代謝をターゲットにすることは 戦略ですが プラスチック性や毒性などの課題に直面します
- PDAに対する効果的な治療法は緊急に必要である.
研究 の 目的:
- PDAの代謝依存性を調査する.
- 臓がんの新たな治療標的を特定する
- PDAにおける de novo オーニチン合成の役割を調査する.
主な方法:
- 遺伝学と薬理学的アプローチを用いた.
- ヒトとマウスで in vitro および in vivo モデルで行われた研究.
- 遺伝子発現と 代謝経路を分析した
主要な成果:
- PDAは,グルタミンからオーニチンアミノトランスフェラーゼ (OAT) 経由でのde novoオーニチン合成に明確な依存を示している.
- この経路はPDA腫瘍の成長に不可欠なポリアミン合成をサポートします.
- 変異したKRASはOAT発現を誘導し,腫瘍細胞のトランスクリプトームとエピジェノームを変化させます.
- この依存性はPDAに特有で,正常な成人の組織とは対照的です.
結論:
- PDAは,ポリアミンの生産のために,OAT媒介のde novoオーニチン合成に依存しています.
- この代謝の脆弱性は,臓がんの治療のための潜在的な治療窓を提示します.
- OATをターゲットにすることで 臓がん治療の戦略を 最小限の毒性で提供できます
関連する概念動画
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Physical Properties of Amines
3.3K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.3K
Amino Acid Biosynthetic Pathways
55
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
55
Urea Cycle
45.2K
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
45.2K
Biosynthesis of Nucleic Acids
94
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
94


